Our Perspectives
THREAD Blog
Supporting Staff Through the Transition to Hybrid Studies
Find out how decentralization allows for greater participation in clinical trials and about the opportunities that are created for a more patient-centric trial design.
Three Tips for Successful eCOA in Global, Decentralized Oncology Trials
The idea behind implementing decentralized clinical trial (DCT) approaches in oncology trials is to improve the participant experience. While participants may still need to visit clinics to receive infusion medications in most oncology studies, DCT elements can ease their trial burden by collecting data remotely in between visits. A key component of this strategy is the effective use of electronic clinical outcome assessments (eCOA).
What we've learned after conducting 100 DCTs
How do you, in a measured way, conduct and scale a decentralized trial? We may not have decentralized trials entirely figured out as we are still learning, adapting, and trying to optimize the decentralized clinical trial approach to be a better experience for everyone involved, however, we can share what we have learned after conducting 100 decentralized studies with THREAD.
Maximizing participant engagement in your clinical trial
Some estimates indicate 85% of trials are failing to recruit enough participants and 80% are delayed due to recruitment challenges and high dropout rates.1 This challenge has been long-standing within the industry, and the adoption of decentralized approaches offer a promising strategy towards maximizing participant recruitment.